@moleculexyz.bsky.social
DeSci biopharma IP tokenization protocol.
Fund & shape early-stage research ideas at https://www.molecule.xyz/
Fund & shape early-stage research ideas at https://www.molecule.xyz/
Today science sits in silos. Tomorrow it lives in markets.
November 9, 2025 at 2:59 AM
Today science sits in silos. Tomorrow it lives in markets.
From our screener: $AUBRAI -- the world's first BioAgent generating and owning onchain IP.
Trained on the mind of @aubreydegrey, powered by @Bioprotocol + Molecule's Proof of Invention rails.
Build for onchain science acceleration👇
Trained on the mind of @aubreydegrey, powered by @Bioprotocol + Molecule's Proof of Invention rails.
Build for onchain science acceleration👇
November 5, 2025 at 8:57 PM
From our screener: $AUBRAI -- the world's first BioAgent generating and owning onchain IP.
Trained on the mind of @aubreydegrey, powered by @Bioprotocol + Molecule's Proof of Invention rails.
Build for onchain science acceleration👇
Trained on the mind of @aubreydegrey, powered by @Bioprotocol + Molecule's Proof of Invention rails.
Build for onchain science acceleration👇
Science is still running on feudal infrastructure.
New systems are inevitable.
New systems are inevitable.
November 2, 2025 at 1:58 AM
Science is still running on feudal infrastructure.
New systems are inevitable.
New systems are inevitable.
Traditional science funding is in crisis.
Meanwhile, tokenized IP is accelerating.
Molecule connects breakthrough science with a breakthrough market.
Meanwhile, tokenized IP is accelerating.
Molecule connects breakthrough science with a breakthrough market.
October 30, 2025 at 11:03 PM
Traditional science funding is in crisis.
Meanwhile, tokenized IP is accelerating.
Molecule connects breakthrough science with a breakthrough market.
Meanwhile, tokenized IP is accelerating.
Molecule connects breakthrough science with a breakthrough market.
Last week, an AI model imagined a cancer treatment -- and got it right.
This week, DrugReflector finds useful compounds 17x faster than traditional research.
The lab is turning into a thinking system --
recursive, transparent, self-improving. 👇
This week, DrugReflector finds useful compounds 17x faster than traditional research.
The lab is turning into a thinking system --
recursive, transparent, self-improving. 👇
October 28, 2025 at 2:04 PM
Last week, an AI model imagined a cancer treatment -- and got it right.
This week, DrugReflector finds useful compounds 17x faster than traditional research.
The lab is turning into a thinking system --
recursive, transparent, self-improving. 👇
This week, DrugReflector finds useful compounds 17x faster than traditional research.
The lab is turning into a thinking system --
recursive, transparent, self-improving. 👇
We’re optimizing for safety, not discovery -- producing endless variations of the same drug.
@fedichev explains how Pharma's risk aversion is dangerous for innovation.
@fedichev explains how Pharma's risk aversion is dangerous for innovation.
October 27, 2025 at 3:28 PM
We’re optimizing for safety, not discovery -- producing endless variations of the same drug.
@fedichev explains how Pharma's risk aversion is dangerous for innovation.
@fedichev explains how Pharma's risk aversion is dangerous for innovation.
For a decade, US Supreme Court rulings pulled biotech inventions into "abstract ideas".
The new PERA (Patent Eligibility Restoration Act) could redraw the innovation landscape
> It redefines what's patentable across biotech, AI, and diagnostics -- potentially ending years of uncertainty.
The new PERA (Patent Eligibility Restoration Act) could redraw the innovation landscape
> It redefines what's patentable across biotech, AI, and diagnostics -- potentially ending years of uncertainty.
October 23, 2025 at 11:20 PM
For a decade, US Supreme Court rulings pulled biotech inventions into "abstract ideas".
The new PERA (Patent Eligibility Restoration Act) could redraw the innovation landscape
> It redefines what's patentable across biotech, AI, and diagnostics -- potentially ending years of uncertainty.
The new PERA (Patent Eligibility Restoration Act) could redraw the innovation landscape
> It redefines what's patentable across biotech, AI, and diagnostics -- potentially ending years of uncertainty.
The model predicted that a known cancer drug under specific immune context, could make “cold” tumors visible to the immune system.
> lab tests confirmed it: combining silmitasertib + low-dose interferon boosted immune visibility ~50%.
> lab tests confirmed it: combining silmitasertib + low-dose interferon boosted immune visibility ~50%.
October 21, 2025 at 2:01 PM
The model predicted that a known cancer drug under specific immune context, could make “cold” tumors visible to the immune system.
> lab tests confirmed it: combining silmitasertib + low-dose interferon boosted immune visibility ~50%.
> lab tests confirmed it: combining silmitasertib + low-dose interferon boosted immune visibility ~50%.
An AI model just made -- and experimentally proved -- a new cancer discovery.
Google & Yale’s Cell2Sentence-Scale (27B) generated a hypothesis that turned out to be correct in living cells.
Scientific singularity is already happening. 👇
Google & Yale’s Cell2Sentence-Scale (27B) generated a hypothesis that turned out to be correct in living cells.
Scientific singularity is already happening. 👇
October 21, 2025 at 2:01 PM
An AI model just made -- and experimentally proved -- a new cancer discovery.
Google & Yale’s Cell2Sentence-Scale (27B) generated a hypothesis that turned out to be correct in living cells.
Scientific singularity is already happening. 👇
Google & Yale’s Cell2Sentence-Scale (27B) generated a hypothesis that turned out to be correct in living cells.
Scientific singularity is already happening. 👇
If developers spent 80% of their time applying to buy a keyboard, tech would be stuck in 1995.
That’s science today -- researchers spend 80% of their time chasing grants, not breakthroughs.
DeSci aims to fix this.
That’s science today -- researchers spend 80% of their time chasing grants, not breakthroughs.
DeSci aims to fix this.
October 14, 2025 at 1:58 PM
If developers spent 80% of their time applying to buy a keyboard, tech would be stuck in 1995.
That’s science today -- researchers spend 80% of their time chasing grants, not breakthroughs.
DeSci aims to fix this.
That’s science today -- researchers spend 80% of their time chasing grants, not breakthroughs.
DeSci aims to fix this.
the longest-living rodent on Earth lives 10x longer than its peers.
now we know why.
a new science paper shows 4 amino acid changes in naked mole-rat cGAS flip a biological switch.
from immune triggering ➝ to DNA repairing
longevity isn't fiction, it's an engineering problem.👇
now we know why.
a new science paper shows 4 amino acid changes in naked mole-rat cGAS flip a biological switch.
from immune triggering ➝ to DNA repairing
longevity isn't fiction, it's an engineering problem.👇
October 13, 2025 at 11:02 PM
the longest-living rodent on Earth lives 10x longer than its peers.
now we know why.
a new science paper shows 4 amino acid changes in naked mole-rat cGAS flip a biological switch.
from immune triggering ➝ to DNA repairing
longevity isn't fiction, it's an engineering problem.👇
now we know why.
a new science paper shows 4 amino acid changes in naked mole-rat cGAS flip a biological switch.
from immune triggering ➝ to DNA repairing
longevity isn't fiction, it's an engineering problem.👇
With Molecule Labs, every milestone, event, and research update is tracked transparently onchain.
October 8, 2025 at 2:40 AM
With Molecule Labs, every milestone, event, and research update is tracked transparently onchain.
$VITASTEM is live on Molecule!
Aging starts in your blood.
$VITASTEM is the first @Aubrai_-generated IP Token targeting your body’s blood-forming stem cells -- the source of age-related decline. 👇
Aging starts in your blood.
$VITASTEM is the first @Aubrai_-generated IP Token targeting your body’s blood-forming stem cells -- the source of age-related decline. 👇
October 8, 2025 at 2:40 AM
$VITASTEM is live on Molecule!
Aging starts in your blood.
$VITASTEM is the first @Aubrai_-generated IP Token targeting your body’s blood-forming stem cells -- the source of age-related decline. 👇
Aging starts in your blood.
$VITASTEM is the first @Aubrai_-generated IP Token targeting your body’s blood-forming stem cells -- the source of age-related decline. 👇
Every step on the roadmap is transparently tracked onchain via Molecule Labs and open to anyone.
October 6, 2025 at 3:29 PM
Every step on the roadmap is transparently tracked onchain via Molecule Labs and open to anyone.
$DICK is live on Molecule!
@D1ckGPT is a BioAgent transforming men's health from taboo ➝ testable
Designed to give recommendations for men's health optimization while collecting verifiable data to fuel research breakthroughs. 👇
@D1ckGPT is a BioAgent transforming men's health from taboo ➝ testable
Designed to give recommendations for men's health optimization while collecting verifiable data to fuel research breakthroughs. 👇
October 6, 2025 at 3:29 PM
$DICK is live on Molecule!
@D1ckGPT is a BioAgent transforming men's health from taboo ➝ testable
Designed to give recommendations for men's health optimization while collecting verifiable data to fuel research breakthroughs. 👇
@D1ckGPT is a BioAgent transforming men's health from taboo ➝ testable
Designed to give recommendations for men's health optimization while collecting verifiable data to fuel research breakthroughs. 👇
for centuries, research agendas were set by a handful of governments and wealthy donors.
@paulkhls & @CryptoHayes discuss how DeSci rewrites that script.
> blockchain turns community capital into research power.
> funding flows where people believe discovery matters most.
@paulkhls & @CryptoHayes discuss how DeSci rewrites that script.
> blockchain turns community capital into research power.
> funding flows where people believe discovery matters most.
October 3, 2025 at 10:58 PM
for centuries, research agendas were set by a handful of governments and wealthy donors.
@paulkhls & @CryptoHayes discuss how DeSci rewrites that script.
> blockchain turns community capital into research power.
> funding flows where people believe discovery matters most.
@paulkhls & @CryptoHayes discuss how DeSci rewrites that script.
> blockchain turns community capital into research power.
> funding flows where people believe discovery matters most.
⏳ science runs on long cycles.
⚡ crypto runs on short attention spans.
at DeSci Summit Singapore, @CryptoHayes & our CEO @paulkhls unpacked how to bridge that gap:
> radical transparency: sharing progress, setbacks, and roadmaps with your community.
⚡ crypto runs on short attention spans.
at DeSci Summit Singapore, @CryptoHayes & our CEO @paulkhls unpacked how to bridge that gap:
> radical transparency: sharing progress, setbacks, and roadmaps with your community.
October 3, 2025 at 1:02 PM
⏳ science runs on long cycles.
⚡ crypto runs on short attention spans.
at DeSci Summit Singapore, @CryptoHayes & our CEO @paulkhls unpacked how to bridge that gap:
> radical transparency: sharing progress, setbacks, and roadmaps with your community.
⚡ crypto runs on short attention spans.
at DeSci Summit Singapore, @CryptoHayes & our CEO @paulkhls unpacked how to bridge that gap:
> radical transparency: sharing progress, setbacks, and roadmaps with your community.
$26T a year -- lost to diseases we already know how to prevent.
the science exists, but remains underfunded + underimplemented.
the problem isn't ideas. it's infrastructure 👇
the science exists, but remains underfunded + underimplemented.
the problem isn't ideas. it's infrastructure 👇
September 29, 2025 at 11:04 PM
$26T a year -- lost to diseases we already know how to prevent.
the science exists, but remains underfunded + underimplemented.
the problem isn't ideas. it's infrastructure 👇
the science exists, but remains underfunded + underimplemented.
the problem isn't ideas. it's infrastructure 👇
IP Tokens offer an open, permissionless, decentralized way to fund scientific research onchain -- and then what?
We're designing the DeSci value flywheel; complete economic cycles where scientific breakthroughs fuel the next generation of discoveries
🧵 ⤵️
We're designing the DeSci value flywheel; complete economic cycles where scientific breakthroughs fuel the next generation of discoveries
🧵 ⤵️
September 29, 2025 at 4:54 PM
IP Tokens offer an open, permissionless, decentralized way to fund scientific research onchain -- and then what?
We're designing the DeSci value flywheel; complete economic cycles where scientific breakthroughs fuel the next generation of discoveries
🧵 ⤵️
We're designing the DeSci value flywheel; complete economic cycles where scientific breakthroughs fuel the next generation of discoveries
🧵 ⤵️
every step of the journey is documented via Molecule labs and pipes directly into the $FIDEL token page.
> this is what open science looks like in motion.
> this is what open science looks like in motion.
September 28, 2025 at 2:00 AM
every step of the journey is documented via Molecule labs and pipes directly into the $FIDEL token page.
> this is what open science looks like in motion.
> this is what open science looks like in motion.
earlier this week:
> Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov tested compounds in human neuronal cell models to measure their effects on protein synthesis accuracy and cellular stress responses.
> Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov tested compounds in human neuronal cell models to measure their effects on protein synthesis accuracy and cellular stress responses.
September 28, 2025 at 2:00 AM
earlier this week:
> Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov tested compounds in human neuronal cell models to measure their effects on protein synthesis accuracy and cellular stress responses.
> Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov tested compounds in human neuronal cell models to measure their effects on protein synthesis accuracy and cellular stress responses.
can we stop toxic protein clumps before parkinson's sets in?
the @Transfidelity_ team is pushing hard toward that goal.
another drop from the frontlines of brain health 👇
the @Transfidelity_ team is pushing hard toward that goal.
another drop from the frontlines of brain health 👇
September 28, 2025 at 2:00 AM
can we stop toxic protein clumps before parkinson's sets in?
the @Transfidelity_ team is pushing hard toward that goal.
another drop from the frontlines of brain health 👇
the @Transfidelity_ team is pushing hard toward that goal.
another drop from the frontlines of brain health 👇
you can expect;
> talks about how RWAs and DeSci are opening up a new asset class, starting with biotech IP
> demos from early-stage bioDAOs
> conversations on longevity, AI x DeSci,
> what it takes to move research from the lab to onchain portfolios
> talks about how RWAs and DeSci are opening up a new asset class, starting with biotech IP
> demos from early-stage bioDAOs
> conversations on longevity, AI x DeSci,
> what it takes to move research from the lab to onchain portfolios
September 27, 2025 at 4:01 AM
you can expect;
> talks about how RWAs and DeSci are opening up a new asset class, starting with biotech IP
> demos from early-stage bioDAOs
> conversations on longevity, AI x DeSci,
> what it takes to move research from the lab to onchain portfolios
> talks about how RWAs and DeSci are opening up a new asset class, starting with biotech IP
> demos from early-stage bioDAOs
> conversations on longevity, AI x DeSci,
> what it takes to move research from the lab to onchain portfolios
If you're in town for @token2049, come to DeSci Singapore.
6 hours of signal on biotech, crypto, and new models for funding science.
We'll be there, speaking about RWAs, @CryptoHayes will do a fireside chat w @paulkhls, we'll hear from upcoming DAOs & more...
6 hours of signal on biotech, crypto, and new models for funding science.
We'll be there, speaking about RWAs, @CryptoHayes will do a fireside chat w @paulkhls, we'll hear from upcoming DAOs & more...
September 27, 2025 at 4:01 AM
If you're in town for @token2049, come to DeSci Singapore.
6 hours of signal on biotech, crypto, and new models for funding science.
We'll be there, speaking about RWAs, @CryptoHayes will do a fireside chat w @paulkhls, we'll hear from upcoming DAOs & more...
6 hours of signal on biotech, crypto, and new models for funding science.
We'll be there, speaking about RWAs, @CryptoHayes will do a fireside chat w @paulkhls, we'll hear from upcoming DAOs & more...